Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Sotera Health Co (NASDAQ: SHC) was $14.86 for the day, up 5.69% from the previous closing price of $14.06. In other words, the price has increased by $5.69 from its previous closing price. On the day, 2.73 million shares were traded. SHC stock price reached its highest trading level at $14.865 during the session, while it also had its lowest trading level at $14.03.
Ratios:
Our analysis of SHC’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 30.03. For the most recent quarter (mrq), Quick Ratio is recorded 2.21 and its Current Ratio is at 2.47. In the meantime, Its Debt-to-Equity ratio is 4.60 whereas as Long-Term Debt/Eq ratio is at 4.55.
On December 06, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $14.
On May 21, 2024, Piper Sandler started tracking the stock assigning a Neutral rating and target price of $13.Piper Sandler initiated its Neutral rating on May 21, 2024, with a $13 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 06 ’24 when WARBURG PINCUS & CO. sold 15,000,000 shares for $15.03 per share. The transaction valued at 225,450,000 led to the insider holds 73,822,952 shares of the business.
WARBURG PINCUS & CO. sold 15,000,000 shares of SHC for $225,450,000 on Sep 06 ’24. The Director now owns 73,822,952 shares after completing the transaction at $15.03 per share. On Sep 06 ’24, another insider, GTCR INVESTMENT XI LLC, who serves as the Director of the company, sold 10,000,000 shares for $15.03 each. As a result, the insider received 150,300,000 and left with 49,215,301 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 4220938496 and an Enterprise Value of 6240301568. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 177.54, and their Forward P/E ratio for the next fiscal year is 16.79. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 14.97. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.75 while its Price-to-Book (P/B) ratio in mrq is 8.26. Its current Enterprise Value per Revenue stands at 5.549 whereas that against EBITDA is 11.879.
Stock Price History:
The Beta on a monthly basis for SHC is 1.80, which has changed by 0.009510875 over the last 52 weeks, in comparison to a change of 0.18157876 over the same period for the S&P500. Over the past 52 weeks, SHC has reached a high of $17.08, while it has fallen to a 52-week low of $9.53. The 50-Day Moving Average of the stock is 26.36%, while the 200-Day Moving Average is calculated to be 17.43%.
Shares Statistics:
SHC traded an average of 1.25M shares per day over the past three months and 1781750 shares per day over the past ten days. A total of 284.05M shares are outstanding, with a floating share count of 146.55M. Insiders hold about 48.41% of the company’s shares, while institutions hold 49.59% stake in the company. Shares short for SHC as of 1753920000 were 14131996 with a Short Ratio of 11.35, compared to 1751241600 on 12303630. Therefore, it implies a Short% of Shares Outstanding of 14131996 and a Short% of Float of 9.16.
Earnings Estimates
Current recommendations for the stock of the company come from 7.0 analysts. The consensus estimate for the next quarter is $0.24, with high estimates of $0.25 and low estimates of $0.23.
Analysts are recommending an EPS of between $0.8 and $0.78 for the fiscal current year, implying an average EPS of $0.79. EPS for the following year is $0.88, with 7.0 analysts recommending between $0.9 and $0.87.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 6 analysts. It ranges from a high estimate of $306.1M to a low estimate of $299.33M. As of the current estimate, Sotera Health Co’s year-ago sales were $285.47MFor the next quarter, 6 analysts are estimating revenue of $305.62M. There is a high estimate of $311.08M for the next quarter, whereas the lowest estimate is $301M.
A total of 6 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.16B, while the lowest revenue estimate was $1.15B, resulting in an average revenue estimate of $1.16B. In the same quarter a year ago, actual revenue was $1.1BBased on 6 analysts’ estimates, the company’s revenue will be $1.23B in the next fiscal year. The high estimate is $1.24B and the low estimate is $1.22B.
